Skip to main content
. 2022 Aug 11;16:946879. doi: 10.3389/fnins.2022.946879

Figure 5.

Figure 5

BBB scale subgroup analysis concerning administration details. (A–C) Subgroup analysis concerning administration timing, injection numbers and administration dose at 28th day after SCI and the WMDs of BBB score over time in different subgroups. *p < 0.05.